Patient self-management of oral anticoagulation: A review

Canadian Journal of Cardiology

Volumn 19, Issue 8, 2003, Pages 931-935

  Sunderji, Rubina ^a,b   Fung, Anthony ^b   Gin, Kenneth ^a,b   Shalansky, Karen ^a,b   Carter, Cedric ^a,b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anticoagulants; Clinical trials; Coagulation; Tests; Valves

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; BLEEDING; BLOOD SAMPLING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DEVICE; DOSE CALCULATION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ECONOMIC ASPECT; HEALTH CARE ACCESS; HEALTH CARE COST; HUMAN; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; OUTCOMES RESEARCH; PATIENT ATTITUDE; PATIENT SATISFACTION; PROTHROMBIN TIME; REVIEW; SELF EVALUATION; SELF MEDICATION; SELF MONITORING; THROMBOEMBOLISM; DOSE RESPONSE; EUROPE; INTERNATIONAL NORMALIZED RATIO; NORTH AMERICA; ORAL DRUG ADMINISTRATION; SELF CARE; UNITED KINGDOM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPE; GREAT BRITAIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; NORTH AMERICA; SELF CARE; THROMBOEMBOLISM; WARFARIN;

EID: 0042233522     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001;119(Suppl):8-21S.
2. Ansell JE, Patel N, Ostrovsky D, Nozzolillo E, Peterson AM. Long-term patient self-management of oral anticoagulation. Arch Intern Med 1995;155:2185-9.
3. Garabedia-Ruffalo S, Gray D, Sax MJ, Ruffalo RL. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm 1985;42:304-8.
4. Pell JP, McIver B, Stuart P, Malone DNS, Alcock J. Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulation clinic. Br J Gen Pract 1993;43:152-4.
5. Hasenkam JM, Kimose HH, Knudsen L, et al. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardiothorac Surg 1997;11:935-42.
6. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care. Arch Intern Med 1998;158:1641-7.
7. Horstkotte D, Piper C, Wiemer M. Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease. J Thromb Thrombolysis 1998;5:S19-24.
8. Koertke H, Minami K, Baisaktaris A, Wagner O, Koerfer R. INR self-management following mechanical heart valve replacement. J Thromb Thrombolysis 2000;9(Suppl):S41-5.
9. Ansell J, Hirsh J, Dalen J, et al. Managing oral anticoagulant therapy. Chest 2001;119(Suppl):22-38S.
10. Wilson-Norton JL, Gibson DL. Establishing an outpatient anticoagulation clinic in a community hospital. Am J Health-Syst Pharm 1996;53:1151-7.
11. Wilt VM, Gums JG, Ahmed OI, Moore LM. Outcome analysis of a pharmacist-managed anticoagulation service. Pharmacotherapy 1995;15:732-9.
12. Cortelazzo S, Finazzi G, Viero P, et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prostheses attending an anticoagulation clinic. Thromb Haemost 1993;43:152-4.
13. Ansell JE, Hughes R. Evolving models of warfarin management: Anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J 1996;132:1095-100.
14. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
15. Kumar S, Haigh JRM, Rhodes LE, et al. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost 1989;62:729-32.
16. Tattersall R, Gale E. Patient self-monitoring of blood glucose and refinements of conventional insulin treatment. Am J Med 1981;70:177-82.
17. Bath PMW, Prasad A, Brown MM, MacGregor GA. Survey of use of anticoagulation in patients with atrial fibrillation. BMJ 1993;30:1045.
18. McCrory DC, Matchar DM, Samsa G, Sanders LL, Prichett EL. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995;155:277-81.
19. The Clinical Quality Improvement Network (CQIN) Investigators. Thromboembolic prophylaxis in 3575 hospitalized patients with atrial fibrillation. Can J Cardiol 1998;14:695-702.
20. Ansell J, Holden A, Knapie N. Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times. Arch Intern Med 1989;149:2509-11.
21. Bernardo A. Post-conference session: Experience with patient self-management of oral anticoagulation. J Thromb Thrombolysis 1996;2:321-5.
22. Watzke HH, Forberg E, Svolba G, Jimenez-Boj E, Krinninger B. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost 2000;83:661-5.
23. Sunderji R, Campbell L, Shalansky K, et al. Outpatient self-management of warfarin therapy: A pilot study. Pharmacotherapy 1999;19:787-93.
24. Sawicki PT, for the Working Group for the study of Patient Self-management of Oral Anticoagulation. A structured teaching and self-management program for patients receiving oral anticoagulation: A randomized controlled trial. JAMA 1999;281:145-50.
25. Cromheecke ME, Levi M, Colly LP, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: A randomised cross-over comparison. Lancet 2000;356:97-102.
26. Samsa GP, Matchar DB. Relationship between test frequency and outcomes of anticoagulation: A literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis 2000;9:283-92.
27. Fitzmaurice DA, Machin SJ, on behalf on the British Society of Haematology Task Force for Haemostasis and Thrombosis. Recommendations for patients undertaking self management of oral anticoagulation. BMJ 2001;323:985-9.
28. Voller H, Glatz J, Taborski U, et al. Background and evaluation plan of a study on self-management of anticoagulation in patients with non-valvular atrial fibrillation (SMAAF study). Zeitschr Kardiol 2000;89:284-8.
29. Vickars L, Bachop L, Michaels D, et al. Comparison of CoaguChek system with laboratory reference method. J Thromb Thrombolysis 2000;9:S71 (Abst)
30. Pierce MT, Crain L, Smith J, Mehta V. Point-of-care versus laboratory measurement of the international normalized ratio. Am J Health-Syst Pharm 2000;57:2271-4.
31. Oral Anticoagulation Monitoring Study Group. Prothrombin measurement using a patient self-testing system. Am J Clin Pathol 2001;115:280-7.
32. Oral Anticoagulation Monitoring Study Group. Point-of-care prothrombin time measurement for professional and patient self-testing use: A multicenter clinical experience. Am J Clin Pathol 2001;115:288-96.
33. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ 1998;159(Suppl 8):S1-29.
34. Kaatz SS, White RH, Hill J, Mascha E, Humphries JE, Becker DM. Accuracy of laboratory and portable monitor international normalized ratio determinations. Arch Intern Med 1995;155:1861-7.
35. Douketis JD, Lane A, Milne J, Ginsberg JS. Accuracy of a portable international normalized ratio monitor in outpatients receiving long-term oral anticoagulant therapy: Comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res 1998;92:11-7.
36. Chapman DC, Stephens MA, Hamann GL, Bailey LE, Dorko CS. Accuracy, clinical correlation, and patient acceptance of two handheld prothrombin time monitoring devices in the ambulatory setting. Ann Pharmacother 1999;33:775-80.
37. Reed C, Rickman H. Accuracy of international normalized ratio determined by portable whole-blood coagulation monitor versus a central laboratory. Am J Health-Syst Pharm 1999;56:1619-23.
38. Lassen JF, Brandslund I, Antonsen S. International normalized ratio for prothrombin times in patients taking oral anticoagulants: Critical difference and probability of significant change in consecutive measurements. Clin Chem 1995;41:444-7.
39. Taborski U, Wittstamm FJ, Bernardo A. Cost-effectiveness of self-managed anticoagulant therapy in Germany. Semin Thromb Haemost 1999;25:103-7.
40. Lafata JE, Martin SA, Kaatz S, Ward RE. Anticoagulation clinics and patient self-testing for patients on chronic warfarin therapy: A cost-effectiveness analysis. J Thromb Thrombolysis 2000;9:S13-9.
41. Taborski U, Muller-Berghaus G. State-of-the-art patient self-management for control of oral anticoagulation. Semin Thromb Haemost 1999;25:43-7.
42. Sethi P, Sunderji R, Shalansky K, Gin K, Fung A. Suitability of warfarin self-management in a random population. J Informed Pharmacother 2000;2:400 (Abst).
43. Voller H. Anticoagulation Self-Management Association of Germany. Anticoagulation Forum 2002;6:2.
44. International Self-Monitoring Association for Anticoagulant Therapy. Anticoagulation Forum 2001;6:1.